The effect of astemizole on bronchial hyperresponsiveness and exercise-induced asthma in children

Allergy
Vibeke BackerE M Laursen

Abstract

The ability of the new generation H1-receptor antagonist, astemizole, to prevent histamine-induced airway obstruction and exercise-induced asthma (EIA) was studied in 20 children with asthma. The study was a randomised clinically controlled trial of oral astemizole versus placebo in a cross-over study. In each of the two treatment periods the children were tested at days 0, 6, 15 and 22 of therapy. The two treatment periods were separated by a washout period of 50 days, and at each visit a bronchial challenge with increasing concentrations of histamine followed by an exercise test was performed, and peak flow and asthmatic symptom score were recorded daily. The children tolerated significantly higher mean concentrations of histamine when treated with astemizole compared with placebo (P less than 0.001). Astemizole postponed the response to exercise, but no change in the maximal response was found. No differences between the treatment periods were found regarding frequency of asthmatic symptoms or the daily recording of peak flow.

References

Jan 1, 1977·The Journal of Allergy and Clinical Immunology·V T Popa
May 1, 1977·Clinical Allergy·D W CockcroftF E Hargreave
Aug 1, 1985·The Journal of Allergy and Clinical Immunology·S T HolgateP H Howarth
Mar 1, 1987·Clinical Allergy·J GerritsenK Knol
Apr 1, 1984·British Journal of Diseases of the Chest·M D CleeA S Robertson
May 19, 1984·British Medical Journal·K R Patel
Aug 1, 1980·British Journal of Pharmacology·M K Church, C F Gradidge
Sep 1, 1980·Thorax·J P Hartley, S G Nogrady
Oct 22, 1949·British Medical Journal·H HERXHEIMER

❮ Previous
Next ❯

Citations

Oct 8, 2003·The Journal of Allergy and Clinical Immunology·Harold S Nelson
Jan 1, 1997·Allergy·A Malick, J A Grant
Nov 1, 1994·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·F E SimonsK J Simons
Jan 22, 2005·Treatments in Respiratory Medicine·Sandra D Anderson
Jan 1, 1990·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·A Bewtra
Jul 9, 2013·Immunology and Allergy Clinics of North America·Vibeke BackerCeleste Porsbjerg
Jul 7, 2001·Pulmonary Pharmacology & Therapeutics·M MincariniG Passalacqua
Jan 1, 1990·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·V Backer
May 15, 1998·Clinics in Sports Medicine·B W Smith, M LaBotz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.